Tailored Drug Development Services

Quotient Sciences has 30 years of experience developing formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,500 molecules at all stages of drug development.

Understanding that early phase clinical testing is a critical milestone in the development of your drug product, we offer clinical trial manufacturing, testing and certification services designed to meet your individual requirements. Our innovative method of building integrated GMP and GCP programs provides a streamlined, flexible approach to drug product supply that reflects your clinical study design and timeline. We understand the time and cost pressures you face during early phase evaluation and work with you to ensure a seamless path from development to clinical trial supply.

Whatever Phase 1 clinical pharmacology study you require, we support you with rapid study startup and recruitment through our locations in Miami, FL, US and Nottingham, UK. Our full-service science and medical teams work with you to design a tailored program based on the needs of your compound and to meet rigorous regulatory requirements.

Quotient Sciences is a trusted, global provider of commercial manufacturing services for small molecule products for niche therapies including oncology, rare diseases and orphan drugs. We can support the production of high-potency compounds at our commercial manufacturing facility based in Philadelphia, PA, US.

The scientific expertise of our Drug Development Consultants across a range of technical disciplines allows us to help our customers in all stages of development, from candidate selection to commercial launch. Our team can work with you to design and implement successful drug development programs based on industry-leading best practices.

Fast access to reliable data is critical for decision making during a study. We provide our customers with earlier interim data and interim PK reports for on-study dosing and formulation decisions to support more informed decision making.